Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Initial Experience of Atezolizumab Plus Bevacizumab for Advanced Hepatocellular Carcinoma in Clinical Practice.

Teiji Kuzuya,Naoto Kawabe,Senju Hashimoto,Ryoji Miyahara,Takuji Nakano,Kazunori Nakaoka,Hiroyuki Tanaka,Yohei Miyachi,Arisa Mii,Yoshinao Tanahashi,Yutaro Kato,Atsushi Sugioka,Yoshiki Hirooka

Cancer diagnosis & prognosis（2021）

Cited 11|Views2
No score
Abstract
Our results suggest that atezolizumab plus bevacizumab might have potential therapeutic safety and efficacy in patients with advanced HCC, including those with disease refractory to lenvatinib. Further studies are needed to confirm the outcomes of atezolizumab plus bevacizumab after lenvatinib failure.
More
Translated text
Key words
Atezolizumab,bevacizumab,hepatocellular carcinoma,lenvatinib,liver function
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined